Literature DB >> 8405777

Hepatocyte spheroids: prolonged hepatocyte viability for in vitro modeling of nongenotoxic carcinogenesis.

R A Roberts1, A R Soames.   

Abstract

To explore peroxisome proliferator-perturbed hepatocyte growth regulation, robust in vitro models of liver are required. This has always posed a problem since isolated hepatocytes show a rapid loss of viability and differentiation status and cease to be useful after 3-4 days in culture. We now describe a model system in which rat hepatocytes are maintained as three-dimensional spheroids. The maintenance of hepatocyte viability and morphology in these cultures is considerably prolonged over that seen in monolayer culture and is comparable to that obtained by the use of collagen gels or dimethyl sulfoxide. The spheroid system is, however, free of any additives that may lead to artifact and free of excessive exogenous protein that may compromise subsequent analyses. Ultrastructural examination reveals extensive interhepatocyte junctional complexes and interdigitation of adjacent membranes together with the presence of bile cannalicular structures. Furthermore, hepatocytes maintained as spheroids retain expression of liver markers such as albumin and also retain their ability to respond to peroxisome proliferators: even after 12 days in culture, treatment with the peroxisome proliferator nafenopin causes a 4.5-fold increase in cytoplasmic volume fraction of peroxisomes. There is a concomitant induction of peroxisomal bifunctional enzyme and cytochrome P4504A, the enzyme markers associated with peroxisome proliferation. The spheroids also maintain expression of the peroxisome proliferator-activated receptor and preliminary data indicate that they are able to undergo replicative DNA synthesis in response to nafenopin. Hepatocyte spheroids will provide us with a model system for studying the early changes in rodent liver nongenotoxic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405777     DOI: 10.1006/faat.1993.1084

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  9 in total

1.  Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications.

Authors:  Poonam Verma; Vipin Verma; Pratima Ray; Alok R Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-20       Impact factor: 2.416

2.  Formation of cylindrical multicellular aggregate (cylindroid) and expression of liver specific functions of primary rat hepatocytes.

Authors:  H Mizumoto; M Hayakami; K Nakazawa; H Ijima; K Funatsu
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

3.  Effects of medium composition on the morphology and function of rat hepatocytes cultured as spheroids and monolayers.

Authors:  G A Hamilton; C Westmorel; A E George
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

4.  Multilayer rat hepatocyte aggregates formed on expanded polytetrafluoroethylene surface.

Authors:  T Tokiwa; J Kano; M Kodama; T Matsumura
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

Review 5.  Organotypic liver culture models: meeting current challenges in toxicity testing.

Authors:  Edward L LeCluyse; Rafal P Witek; Melvin E Andersen; Mark J Powers
Journal:  Crit Rev Toxicol       Date:  2012-05-15       Impact factor: 5.635

Review 6.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

Review 7.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

8.  Morphological and Functional Analysis of Hepatocyte Spheroids Generated on Poly-HEMA-Treated Surfaces under the Influence of Fetal Calf Serum and Nonparenchymal Cells.

Authors:  Ali Acikgöz; Shibashish Giri; Man-Gi Cho; Augustinus Bader
Journal:  Biomolecules       Date:  2013-03-07

9.  Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy.

Authors:  Samuel J I Blackford; Soon Seng Ng; Joe M Segal; Aileen J F King; Amazon L Austin; Deniz Kent; Jennifer Moore; Michael Sheldon; Dusko Ilic; Anil Dhawan; Ragai R Mitry; S Tamir Rashid
Journal:  Stem Cells Transl Med       Date:  2018-11-19       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.